These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 4877410)
41. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria. Hokama S Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097 [No Abstract] [Full Text] [Related]
42. [On qualitative demonstration of tuberculostatics in the control of taking of drugs]. Grunert M; Reutgen H; Iwainsky H Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136 [No Abstract] [Full Text] [Related]
44. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences. de Kantor IN; Barrera L Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909 [TBL] [Abstract][Full Text] [Related]
45. [Therapeutic effects of secondary antitubercular agents at our hospital]. Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832 [No Abstract] [Full Text] [Related]
46. [Clinical problems of resistance to secondary antitubercular agents]. Baba H; Takahashi R; Nakai T; Torii R; Yo I Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830 [No Abstract] [Full Text] [Related]
51. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis. Ogawa T; Motomura K Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006 [No Abstract] [Full Text] [Related]
52. Newer and second-line drugs in the treatment of drug-resistant tuberculosis in children. Steiner M Med Clin North Am; 1967 Sep; 51(5):1153-67. PubMed ID: 4297572 [No Abstract] [Full Text] [Related]
53. [Tuberculostatic tolerance of a tuberculous kidney]. Strauss I Z Urol Nephrol; 1969; 62(9):651-6. PubMed ID: 4325816 [No Abstract] [Full Text] [Related]
54. [Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice]. Matsumiya T; Freerksen E; Rosenfeld M Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):30-4. PubMed ID: 4991617 [No Abstract] [Full Text] [Related]
55. [Drug therapy of tuberculosis. Advanced training and working conference at the Central Hospital Gauting of the State Insurance Company of Upper Bavaria on Nov. 9, 1968]. Erhard G Med Klin; 1969; 64(26):1215-7. PubMed ID: 4979959 [No Abstract] [Full Text] [Related]
56. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)]. Belogurova VP; Ivanitskaia NN Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204 [No Abstract] [Full Text] [Related]
57. [Evaluation of the therapeutic effects of secondary antitubercular agents]. Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119 [No Abstract] [Full Text] [Related]
58. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations]. Fedotova ZN; Gur'ian IE; Kochetov BI Probl Tuberk; 1972; 50(11):21-4. PubMed ID: 4630564 [No Abstract] [Full Text] [Related]